North Caldwell, NJ, United States of America

Rodney I Fryer

This inventor holds 68 USPTO granted patents, primarily in Benzazepine Chemistry (CPC class 2602). Top assignee: Hoffmann-La Roche Inc.. Active years: 1976-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rodney I Fryer. Retrieved from https://idiyas.com/inventor/rodney-i-fryer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 171(Granted Patents)

Forward Citations (Not Self Cited) = 162(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • North Cadwell, NJ (US) (1976)
  • North Caldwell, NJ (US) (1976 - 1985)

Company Filing History:


Years Active: 1976-1985

Loading Chart...
Areas of Expertise:
Benzazepines
Anxiolytic Agents
Imidazodiazepines
Pyrimidines
Thiazoles
Pyrazoles
Intermediates
Processes
Carbonitriles
Triazoles
Sedatives
Phenyl Derivatives
68 patents (USPTO):Explore Patents

Title: The Innovative Mind of Rodney I Fryer

Introduction

Rodney I Fryer, an esteemed inventor based in North Caldwell, NJ, has made significant contributions to the field of pharmacology through the development of novel compounds. With an impressive portfolio of 68 patents, Fryer has focused on creating therapeutic agents that address critical health issues, particularly in the domains of anxiety and sedation.

Latest Patents

Among his latest innovations are two notable patents that explore the potential of benzazepine derivatives. The first patent details the synthesis of 3H-2-benzazepines as well as 4,5-dihydro-3H-2-benzazepines, emphasizing a unique formula characterized by various substitutions that include chloro, bromo, and different radicals. These compounds hold promise for pharmaceutical applications, particularly in developing effective medications.

Another patent highlights the pyrimido[4,5-d][2]benzazepines, which are designed to function as sedative and anxiolytic agents. This patent outlines intricate structures and processes for synthesizing these compounds, showcasing their potential to benefit those requiring anxiety relief and sedation.

Career Highlights

Rodney I Fryer's career is marked by his unwavering commitment to scientific innovation at Hoffmann-La Roche Inc., a leading global pharmaceutical company. Here, he has been actively engaged in research and development, contributing to numerous projects that aim to improve the quality of life for patients through effective medications.

Collaborations

Fryer has worked alongside notable colleagues such as Armin Walser and Eugene J Trybulski. These collaborations have fostered an exchange of expertise, leading to advancements in their respective research endeavors and contributing to the successful development of new therapeutic products.

Conclusion

In conclusion, Rodney I Fryer's dedication to the field of pharmaceuticals, exemplified by his extensive patent portfolio and impactful collaborations, marks him as a leading inventor in the modern scientific landscape. His contributions not only advance medical knowledge but also pave the way for innovative solutions to pressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…